The Michigan Department of Health and Human Services implemented and evaluated two initiatives designed to enhance provider knowledge of patients appropriate for breast and/or ovarian cancer genetic risk assessment and hereditary breast and ovarian cancer (HBOC) syndrome testing. The first initiative targeted select providers who had diagnosed patients meeting HBOC risk criteria. Specifically, the initiative used 2008–2009 state cancer registry data to identify all providers who had diagnosed breast cancers in women ≤50 years of age, male breast cancers, and ovarian cancers in four health systems with newly established cancer genetics clinics. Using a method coined bidirectional reporting (BDR), reports highlighting how many of these cases ...
The Cancer Risk Education Intervention Tool (CREdIT) is a computer-based (non-interactive) slide pre...
Patients with a lower educational or a migrant background seem to have poorer access to breast cance...
Problem statement: Mutations in the genetic material BRCA I/II are linked to increased incidence of ...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
The National Comprehensive Cancer Network (NCCN) guidelines are the gold standard in hereditary canc...
In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Dise...
Objective: To increase identification and genetic referral rates for women at risk of Hereditary Bre...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
The discovery of the breast and ovarian cancer predisposition genes, BRCA1 and BRCA2, has led to the...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
The Cancer Risk Education Intervention Tool (CREdIT) is a computer-based (non-interactive) slide pre...
Patients with a lower educational or a migrant background seem to have poorer access to breast cance...
Problem statement: Mutations in the genetic material BRCA I/II are linked to increased incidence of ...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
The National Comprehensive Cancer Network (NCCN) guidelines are the gold standard in hereditary canc...
In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Dise...
Objective: To increase identification and genetic referral rates for women at risk of Hereditary Bre...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
The discovery of the breast and ovarian cancer predisposition genes, BRCA1 and BRCA2, has led to the...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
The Cancer Risk Education Intervention Tool (CREdIT) is a computer-based (non-interactive) slide pre...
Patients with a lower educational or a migrant background seem to have poorer access to breast cance...
Problem statement: Mutations in the genetic material BRCA I/II are linked to increased incidence of ...